Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial

The Lancet
Apr 10, 2021 Volume 397 Number 10282 p1325-1418
https://www.thelancet.com/journals/lancet/issue/current

 

Articles
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
Katherine R W Emary, et al on behalf of the COVID-19 Genomics UK consortium, the AMPHEUS Project,
and the Oxford COVID-19 Vaccine Trial Group
Open Access